Study in early diagnosis of adrenal carcinoma
Our team is currently designing an academic multicentric study entitled OPTIM-ACC, which aims to evaluate the role of metabolomics and liquid biopsy in the early diagnosis of adrenocortical carcinoma (ACC) and in the detection of its recurrence (annoucement letter attached).
This project has been made possible thanks to the generous fundraising initiative of a patient’s family (“Mathilde et ses étoiles”). The study sponsor is the Cliniques universitaires Saint-Luc (UCLouvain).
Given the very low incidence of ACC (approximately 1–2 cases per million person-years), this study will be multicentric, and collaboration across endocrine centers will be essential.
Read more
